Vyome Holdings Inc (HIND)

Jun 14, 2026

ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why - MSN

Jun 14, 2026

Jun 13, 2026

HIND Q1 2026 Earnings: EPS Surprises Positive as Cost Control Takes Center StageAnalyst Earnings Estimate - newsline.com

Jun 13, 2026

Jun 13, 2026

HIND Q1 2026 Earnings: EPS Surprises with 18.3% Beat Amid Revenue UncertaintyFiscal Year Earnings - newsline.com

Jun 13, 2026

Jun 05, 2026

HIND Q1 2026 Earnings: EPS Beats Estimates as Losses Narrow; Stock RisesCFO Commentary Report - newsline.com

Jun 05, 2026

Jun 04, 2026

Vyome to present VT-1953 Phase 2 data at cancer research meeting - Investing.com

Jun 04, 2026

Jun 03, 2026

Earnings call transcript: Vyome Holdings Q1 2026 shows strong cash position - Investing.com

Jun 03, 2026

May 31, 2026

HIND Q1 2026 Earnings: EPS Beats Estimates as Development Pipeline AdvancesSurprise Factor Analysis - The Legal Advocate

May 31, 2026

May 29, 2026

HIND Q1 2026 Earnings: EPS Surpasses Estimates as Company Advances PipelineROA Comparison - The Legal Advocate

May 29, 2026

May 29, 2026

Vyome Holdings reports Q1 2026: $8.8M cash, $10.2M total assets, net loss $986K - TradingView

May 29, 2026

May 28, 2026

Press Release: Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet - Moomoo

May 28, 2026

May 28, 2026

Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet - BioSpace

May 28, 2026

May 28, 2026

Vyome Holdings (HIND.US) will release its earnings report on June 3. - Moomoo

May 28, 2026

May 27, 2026

HIND Q1 2026 Earnings: EPS Beats Estimates Despite Revenue AbsenceDownward Estimate Revision - The Legal Advocate

May 27, 2026

May 25, 2026

HIND Q1 2026 Earnings: EPS Beat Despite Limited Revenue VisibilityEPS Consistency Score - The Legal Advocate

May 25, 2026

May 23, 2026

Vyome Holdings Inc. (HIND) Q4 2025 Earnings: Significant EPS Beat Highlights Cost DisciplineProfessional Trade Ideas - Newser

May 23, 2026

May 22, 2026

HIND News | VYOME HOLDINGS INC (NASDAQ:HIND) - ChartMill

May 22, 2026

May 15, 2026

Vyome Holdings (HIND) Stock Analysis: -1.56% Loss — Key Levels 2026-05-15Retail Trader Ideas - Newser

May 15, 2026

May 13, 2026

Vyome Holdings inks agreement with Impetis Biosciences to in-license two selective JAK inhibitor assets - BioSpectrum India

May 13, 2026

May 13, 2026

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs - Indian Pharma Post

May 13, 2026

May 12, 2026

Vyome Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 12, 2026

May 12, 2026

Vyome strikes deal with Impetis Biosciences, opening a ~$57B market opportunity - marketscreener.com

May 12, 2026

May 12, 2026

Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity - The Joplin Globe

May 12, 2026

May 08, 2026

How Vyome Holdings (HIND) compares to the market average (Weakens) 2026-05-08Dealer Positioning - The Legal Advocate

May 08, 2026

May 01, 2026

HIND Stock Price, Quote & Chart | VYOME HOLDINGS INC (NASDAQ:HIND) - ChartMill

May 01, 2026

Apr 29, 2026

HIND (Vyome Holdings) shares fall 2.86% despite Q4 2025 EPS beating analyst estimates by a wide 40% margin.Stock Market Community - newser.com

Apr 29, 2026

Apr 28, 2026

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings - Indian Pharma Post

Apr 28, 2026

Apr 27, 2026

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings, Inc. - Indian Pharma Post

Apr 27, 2026

Apr 24, 2026

What could go wrong with Vyome Holdings (HIND) stock | Q4 2025: Earnings Beat EstimatesBeat Estimates - newser.com

Apr 24, 2026

Apr 23, 2026

Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026 - BioSpace

Apr 23, 2026

Apr 23, 2026

Maxim Group Maintains Vyome Holdings(HIND.US) With Buy Rating, Maintains Target Price $15 - Moomoo

Apr 23, 2026

Apr 22, 2026

Vyome reports positive phase 2 results for cancer wound treatment By Investing.com - Investing.com Australia

Apr 22, 2026

Apr 22, 2026

Vyome reports positive phase 2 results for cancer wound treatment - Investing.com

Apr 22, 2026

Apr 21, 2026

HIND Financials: Income Statement, Balance Sheet & Cash Flow | Vyome Holdings, Inc. - Stock Titan

Apr 21, 2026

Apr 20, 2026

Vyome Holdings (HIND) Stock Consolidates (Eye on Rally) 2026-04-20Social Trading Insights - Xã Châu Thành

Apr 20, 2026

Apr 18, 2026

Vyome Holdings (HIND) Stock: Why Institutions Watch It (Ticks Lower) 2026-04-18Shared Trade Ideas - Xã Thanh Hà

Apr 18, 2026

Apr 18, 2026

Vyome Holdings (HIND) Stock Historical Volatility (Ticks Lower) 2026-04-18Stock Surge Alerts - The Legal Advocate

Apr 18, 2026

Apr 11, 2026

Vyome Holdings (STU:24O0) PB Ratio : 0.00 (As of Apr. 16, 2026) - GuruFocus

Apr 11, 2026

Apr 07, 2026

Vyome Holdings, Inc. (HIND) stock price, news, quote and history - Yahoo Finance UK

Apr 07, 2026

Apr 06, 2026

Breaking News about Vyome Holdings, Inc.Common Stock (Nasdaq:HIND) - FinancialContent

Apr 06, 2026

Apr 06, 2026

Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026 - BioSpace

Apr 06, 2026

Apr 06, 2026

Vyome to present VT-1953 Phase 2 data at cancer research meeting By Investing.com - Investing.com South Africa

Apr 06, 2026

Apr 04, 2026

HIND Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 04, 2026

Apr 01, 2026

Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027 - Indian Pharma Post

Apr 01, 2026

Apr 01, 2026

RSLS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 01, 2026

Mar 30, 2026

Vyome Holdings Inc (HIND) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... By GuruFocus - Investing.com Canada

Mar 30, 2026

Mar 28, 2026

HIND Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 28, 2026

Mar 27, 2026

HIND Should I Buy - Intellectia AI

Mar 27, 2026